| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/27/2004 | CN1172666C Compositions cotaining benzamide disulfide derivative for treating allergic diseases |
| 10/27/2004 | CN1172665C Combined medicinal preparation of sodium/hydrogen exchange-pump inhibitor and medicine for treatment of angiocardiopathy |
| 10/27/2004 | CN1172664C Agent for lowering prolactin |
| 10/27/2004 | CN1172663C Application of gamma-vinyl-gamma-azyl butyrate in treatment of addition and addiction-related behavior |
| 10/27/2004 | CN1172661C Estradiol-containing patch for transdermal administration of hormones |
| 10/27/2004 | CN1172659C Method for making a pharmaceutial formulation |
| 10/26/2004 | US6809214 Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 10/26/2004 | US6809204 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 10/26/2004 | US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809189 Apoptin-associating protein |
| 10/26/2004 | US6809188 By reacting erythromycin a n-oxide with a methylating agent to obtain 6-o-methylerythromycin a n-oxide and treating with a reducing agent; high yield |
| 10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
| 10/26/2004 | US6809175 Cadherin derived growth factor and its use |
| 10/26/2004 | US6809120 Protecting normal cells; overcoming drug resistance and/or toxicity |
| 10/26/2004 | US6809119 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 10/26/2004 | US6809118 Histone deacetylase inhibitors; antiproliferative agents; antiinflammatory agents |
| 10/26/2004 | US6809117 Therapeutic uses of nitric oxide inhibitors |
| 10/26/2004 | US6809116 Materials and methods for the treatment of depression |
| 10/26/2004 | US6809115 Mixture has a synergistic, weight loss effect |
| 10/26/2004 | US6809114 4-aminobenzopyran derivatives |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809112 Administering a sexually therapeutically effective amount of a compound having the formula like (5r)-5-(methylamino)-5,6-dihydro-4h-imidazo(4,5,1-ij)quinoline-2(1h)-thione |
| 10/26/2004 | US6809111 Antiinflammatory agents; analgesics |
| 10/26/2004 | US6809109 E.g., 5-bromo-2-(4-chloroanilino)-4-(2,4,6-trimethylphenoxy) pyridine-n-oxide; administering along with an hiv reverse transcriptase inhibitors (polymerase), hiv protease inhibitors, fusion inhibitors or ccr-5; kits |
| 10/26/2004 | US6809107 Neurodegenerative diseases |
| 10/26/2004 | US6809106 Antiproliferation agents; such as 4-(2-methoxyphenoxy)-anilino-3-chloro-6,7-dimethoxyquinoline |
| 10/26/2004 | US6809103 E-ring expanded camptothecin derivatives |
| 10/26/2004 | US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis |
| 10/26/2004 | US6809101 Compounds having anti-hepatitis C virus effect |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809099 Saframycins, analogues and uses thereof |
| 10/26/2004 | US6809098 Compounds |
| 10/26/2004 | US6809097 Antiangiogenic and/or vascular permeability |
| 10/26/2004 | US6809096 Such as 11-methoxy-7h-pyrido(4,3,2-de)(1,7)phenanthroline-7-one; antitumor agents |
| 10/26/2004 | US6809095 Novel antitobesity and hypocholesterolemic compounds lower total cholesterol; increase high density lipoprotein (hdl) and decrease low denstiy lipoprotein |
| 10/26/2004 | US6809094 N-fused hetercyclo-1,4- or -1,5- diazabicyclo derivatives; nicotinic receptor agonists; central nervous system (cns) |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809091 Substances capable of inducing apoptosis |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 10/26/2004 | US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 10/26/2004 | US6809087 Sodium salt of 2-hydroxy-5-((4-(3-(4-((2-methyl-1h-imidazo-(4,5-c)pyridin-1-yl)methyl)-1 -piperidinyl)-3-oxo-1-phenyl-1-propenyl)phenyl)azo)benzoic acid; inflammatory bowel disease |
| 10/26/2004 | US6809086 Dehydroxylation; silylation; for accelerating activity of fibroblast growth factor |
| 10/26/2004 | US6809085 Adherent N,O-Carboxymethylchitosan drug delivery devices for moist tissue and methods of their use |
| 10/26/2004 | US6809084 Preventing destruction of pancreatic beta cells |
| 10/26/2004 | US6809083 Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections |
| 10/26/2004 | US6809082 Synthetic transfection vectors |
| 10/26/2004 | US6809080 Useful as antibacterial and antiprotozoal agents in mammals, including man, as well as in fish and birds. |
| 10/26/2004 | US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders |
| 10/26/2004 | US6808875 Methods for screening cellular proliferation using isotope labels |
| 10/26/2004 | US6808739 Drying method for selectively removing volatile components from wet coatings |
| 10/26/2004 | US6808725 Food additive |
| 10/26/2004 | US6808723 Gastric acid secretion |
| 10/26/2004 | US6808721 Methods for coating pharmaceutical core tablets |
| 10/26/2004 | US6808719 Interior core in well containing active materials; aperture to exterior |
| 10/26/2004 | US6808718 Method of treating farrowing sows to increase pig production |
| 10/26/2004 | US6808716 N-acetylamino acids, related N-acetyl compounds and their topical use |
| 10/26/2004 | CA2418634C Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 10/26/2004 | CA2395217C Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 10/26/2004 | CA2335713C Oral dosage form |
| 10/26/2004 | CA2316919C Novel macrolides |
| 10/26/2004 | CA2303446C Carbapenem derivatives and a preparation method thereof |
| 10/26/2004 | CA2295752C Novel process for manufacturing paroxetine solid dispersions |
| 10/26/2004 | CA2294247C Antioxidant enhancement of therapy for hyperproliferative conditions |
| 10/26/2004 | CA2276730C Emulsion vehicle for poorly soluble drugs |
| 10/26/2004 | CA2263888C Methods and compositions for the detection of cervical cancer |
| 10/26/2004 | CA2261827C Use of amines to produce drugs for preventing tumour cell proliferation |
| 10/26/2004 | CA2180837C Microgranules of 5-nitro imidazole derivatives |
| 10/26/2004 | CA2161004C Active ingredient patch |
| 10/26/2004 | CA2132514C Antiproliferative quinazolines |
| 10/26/2004 | CA2127411C Tricyclic derivatives |
| 10/26/2004 | CA2127215C New use of beta-naphtoquinone derivatives and of their salts for the production of a medicament to inhibit platelet aggregation |
| 10/26/2004 | CA2127214C New use of beta-naphtoquinone derivatives and of their salts for the production of a medicament which accelerate the growth of endothelial cells to inhibit no synthtases |
| 10/26/2004 | CA2111283C Process for preparation of indolopyrrolocarbazole derivatives |
| 10/26/2004 | CA2110313C Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
| 10/26/2004 | CA2099303C Dextromethorphan continuous lozenge manufacturing process |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/22/2004 | CA2465017A1 Reagents for detecting efavirenz |
| 10/21/2004 | WO2004090691A2 Method and apparatus for system management using codebook correlation with symptom exclusion |
| 10/21/2004 | WO2004090541A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY |
| 10/21/2004 | WO2004090108A2 Irna conjugates |
| 10/21/2004 | WO2004089992A1 Modified acacia and use thereof |
| 10/21/2004 | WO2004089971A1 Topical antiandrogenic steroids |
| 10/21/2004 | WO2004089970A2 Crystalline 19-norsteroids |
| 10/21/2004 | WO2004089967A1 HETEROARYL 5-THIO-β-D-GLUCOPYRANOSIDE DERIVATIVES AND REMEDIES FOR DIABETES CONTAINING THE SAME |
| 10/21/2004 | WO2004089966A1 METHOD FOR SELECTIVE PREPARATION OF HETEROARYL 5-THIO- β-D-ALDOHEXOPYRANOSIDE |
| 10/21/2004 | WO2004089965A2 Topiramate and processes for the preparation thereof |
| 10/21/2004 | WO2004089964A1 Lipid-regulating agent and use thereof |
| 10/21/2004 | WO2004089963A1 Compositions and methods for facilitating reaction at room temperature |
| 10/21/2004 | WO2004089957A1 A novel crystalline form of dorzolamide hydrochloride |
| 10/21/2004 | WO2004089956A1 Novel amino acid dysiherbaine |
| 10/21/2004 | WO2004089953A1 Purin-6-one-derivatives |
| 10/21/2004 | WO2004089952A1 Novel crystalline forms of abacavir sulfate |
| 10/21/2004 | WO2004089943A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues |
| 10/21/2004 | WO2004089942A2 Benzimidazolidinone derivatives as muscarinic agents |
| 10/21/2004 | WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 10/21/2004 | WO2004089935A1 Novel crystalline forms of s-omeprazole magnesium |
| 10/21/2004 | WO2004089934A1 Processes for the preparation of n-((((pyridinyloxy) -phenylamino) quinazolinyl)- allyl) acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates |
| 10/21/2004 | WO2004089933A1 Novel crystal of fluorobenzamide derivative |